Members |
targetComponentId |
Morphine sulfate 30mg/sachet granules for suspension |
Morphine sulfate 3 mg/mL oral suspension |
Morphine sulfate 35mg rectal tampon |
Morphine sulfate 35 mg rectal suppository |
Morphine sulfate 50mg + naltrexone hydrochloride 2mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
Morphine sulfate 50mg + naltrexone hydrochloride 2mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
Morphine sulfate 50mg rectal tampon |
Morphine sulfate 50 mg rectal suppository |
Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
Morphine sulfate 60mg/sachet granules for suspension |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
Morphine sulfate 75mg rectal tampon |
Morphine sulfate 75 mg rectal suppository |
Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
Morphine sulfate 80mg m/r capsule |
Product containing only morphine in oral dose form (medicinal product form) |
Morphine sulfate 80mg prolonged-release oral capsule |
Product containing only morphine in oral dose form (medicinal product form) |
Morphine tartrate+cyclizine |
Product containing cyclizine and morphine (medicinal product) |
Morphinian antitussive agent |
Morphinan opioid |
Mosquito-borne bunyavirus encephalitis |
Mosquito-borne orthobunyavirus encephalitis |
Mosquito-borne bunyavirus fever |
Mosquito-borne orthobunyavirus fever |
Mother currently breast-feeding |
Mother currently breastfeeding |
Mother currently breast-feeding |
Mother currently breastfeeding |
Mother of subject |
Mother |
Motility stimulant |
Motility stimulant (substance) |
Mould mix RAST test |
Fungal mix specific IgE antibody measurement |
Mould mix RAST test |
Fungal mix specific IgE antibody measurement |
Mouse mammary tumor virus |
Mouse mammary tumour virus |
Mouse mix RAST test |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
Mouse mix RAST test |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
Mouse mix radioallergosorbent test |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
Mouth symptom NOS |
Mouth symptoms |
Mouth symptom NOS |
Mouth symptoms |
Moved elsewhere |
Moved elsewhere |
Movement measurement NEC |
Assessment of body movement (procedure) |
Movement measurement NEC |
Assessment of body movement (procedure) |
Moxifloxacin hydrochloride |
Product containing moxifloxacin (medicinal product) |
Moxifloxacin hydrochloride 0.5% ophthalmic solution |
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Moxifloxacin hydrochloride 1.6mg/mL infusion solution 250mL bag |
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection |
Mucinous cystadenoma, borderline malignancy |
Mucinous cystic tumor of borderline malignancy (morphologic abnormality) |
Mucinous cystic tumor with moderate dysplasia |
Mucinous cystadenoma (morphologic abnormality) |
Mucolytics adverse reaction |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
Mucosal-associated lymphoid tissue (MALT) lymphoma |
Marginal zone B-cell lymphoma |
Mucositis following chemotherapy |
Inflammation of mucous membrane due to and following chemotherapy |
Mucous membrane anti-infective |
Anti-infective agent (substance) |
Mucous membrane antibiotic |
Antibacterial |
Mucous membrane antifungal agent |
Antifungal |
Mucous membrane antiviral agent |
Substance with antiviral mechanism of action (substance) |
Mullet - dietary |
Mullet (substance) |
Multiceps |
Taenia |
Multiceps |
Taenia |
Multiceps brauni |
Taenia brauni (organism) |
Multiceps serialis |
Taenia serialis |
Multicystic kidney |
A rare congenital anomaly of the kidney and urinary tract (CAKUT) in which one or both kidneys (unilateral or bilateral MCDK respectively) are large, distended by multiple cysts, and non-functional. Unilateral MCDK is typically asymptomatic if the other kidney is fully functional but may occasionally present with abdominal obstructive signs when the cysts become too large. Bilateral MCDK is considered a lethal entity and neonates present with features of the Potter sequence, severe pulmonary hypoplasia and severe renal failure, and generally die shortly after birth. |
Multiple V-Y plasties |
Reconstruction of skin using local V-Y advancement flap (procedure) |
Multiple closed fractures of skull AND/OR face with cerebral laceration AND/OR contusion |
Traumatic brain injury |
Multiple closed fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
Multiple closed fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
Multiple complications due to diabetes mellitus |
Complication due to diabetes mellitus (disorder) |
Multiple complications due to malnutrition related diabetes |
Disorder due to malnutrition related diabetes mellitus |
Multiple complications due to type 1 diabetes mellitus |
Disorder due to type 1 diabetes mellitus |
Multiple complications due to type 2 diabetes mellitus |
Disorder due to type 2 diabetes mellitus (disorder) |
Multiple complications of type II diabetes mellitus |
Disorder due to type 2 diabetes mellitus (disorder) |
Multiple congenital anomalies NOS |
Congenital malformation syndrome (disorder) |
Multiple congenital anomalies NOS |
Congenital malformation syndrome (disorder) |
Multiple congenital articular rigidities |
A rare sporadic arthrogryposis syndrome with characteristics of multiple congenital contractures presenting in a very specific pattern. It is typically symmetric, involving all four limbs, with internally rotated shoulders, fully extended and fixed elbows, the wrists fixed in flexion, partially flexed fingers, hips fixed in flexion or extension, adducted or abducted and sometimes dislocated. The knees may be fixed in extension or flexion and the feet are usually in severe equinovarus position. The jaw and trunk are relatively spared. Normal limb muscle tissue is replaced by fatty, fibrous tissue. |
Multiple electrolyte infusion allergy |
Allergy to drug |
Multiple endocrine deficiency syndrome, NEC |
Multiple endocrine deficiency syndrome |
Multiple extreme injuries of abdominal organs with open wound into cavity |
Severe crushing injury of abdominal organs with open wound into cavity |
Multiple extreme injuries of abdominal organs without open wound into cavity |
Severe crushing injury of abdominal organs without open wound into cavity |
Multiple fractures, unspecified |
Fracture of multiple bones (disorder) |
Multiple fractures, unspecified |
Fracture, multiple bone sites |
Multiple myeloma, no International Classification of Diseases for Oncology subtype |
Plasma cell myeloma |
Multiple non-ossifying fibromatosis |
Neurofibromatosis type 1 |
Multiple open fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
Multiple open fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
Multiple open mouth wounds with complication |
Multiple open mouth wounds |
Multiple open wounds of face with complication |
Multiple open wounds of face |
Multiple open wounds of lower limb with complication |
Multiple open wounds of lower limb |
Multiple open wounds of shoulder with complication |
Multiple open wounds of shoulder (disorder) |
Multiple open wounds of upper arm with complication |
Multiple open wounds of upper arm |
Multiple open wounds of upper limb with complication |
Open wound of multiple sites of upper limb |
Multiple open wounds with complication |
Multiple open wounds |
Multiple open wounds without complication |
Multiple open wounds |
Multiple pregnancy NOS |
Multiple pregnancy |
Multiple pregnancy NOS |
Multiple pregnancy |
Multiple pregnancy NOS |
Multiple pregnancy |
Multiple pregnancy with malpresentation NOS |
Multiple pregnancy with malpresentation |
Multiple pregnancy with malpresentation unspecified |
Multiple pregnancy with malpresentation |
Multiple-level cervical spondylosis with myelopathy |
Myelopathy due to multiple-level cervical spondylosis (disorder) |
Multiple-level cervical spondylosis with radiculopathy |
Radiculopathy due to multiple-level cervical spondylosis |
Multivitamin preparation |
Multivitamin agent (substance) |
Multivitamin preparations |
Multivitamin agent (substance) |
Multivitamin+mineral preparations |
Multivitamin multimineral supplement (substance) |
Multivitamin+mineral preparations |
Multivitamin multimineral supplement (substance) |
Multivitamins |
Multivitamin agent (substance) |
Mumps - other |
Mumps |
Mumps - other |
Mumps |
Mumps with complication |
Mumps |
Mumps with no complication |
Mumps |
Mumps with other specified complication |
Mumps |
Mumps without complication |
Mumps |
Mumps-measles-rubella not given |
Measles mumps and rubella vaccination not done (situation) |
Mupirocin calcium 2% cream |
Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream |
Mural cardiac aneurysm |
Aneurysm of heart |